LZAP Inhibits p38 MAPK Phosphorylation and Activity
Author Information
Author(s): An Hanbing, Lu Xinyuan, Liu Dan, Yarbrough Wendell G.
Primary Institution: Vanderbilt University
Hypothesis
LZAP acts as a tumor suppressor by inhibiting p38 MAPK activity.
Conclusion
LZAP inhibits p38 MAPK phosphorylation and activity, potentially through increased association with the Wip1 phosphatase.
Supporting Evidence
- LZAP expression is lost in a subset of human head and neck squamous cell carcinoma.
- Loss of LZAP enhances tumor growth and angiogenesis in xenograft models.
- LZAP inhibits p38 phosphorylation in a dose-dependent manner.
- Depletion of LZAP increases p38 phosphorylation in various cell types.
Takeaway
LZAP is a protein that helps stop cancer cells from growing by blocking a signal called p38 MAPK. When LZAP is missing, the cancer cells can grow faster.
Methodology
The study involved co-immunoprecipitation and immunoblotting to analyze the interaction between LZAP and p38 MAPK in various cell lines.
Limitations
The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website